Health
Moderna COVID-19 vaccine well-tolerated, generates immune response in older adults: Study – The Indian Express
The study, published in the New England Journal of Medicine, noted that the experimental vaccine, mRNA-1273, was well-tolerated by the older trial participants,…
By: AP | Boston |
Updated: September 30, 2020 7:40:28 pm
According to the researchers from NIAID, older adults are more vulnerable to complications of COVID-19, and are an important population for vaccination. (AP/File)Results from the Phase 1 trial of an investigational COVID-19 vaccine co-developed by researchers at the US National Institute of Allergy and Infectious Diseases (NIAID), and the American biotech company Moderna have shown that it is well-tolerated and generates a strong immune…
-
General13 hours agoQueensland announced as 2027 Women’s Softball World Cup host in first Australian event since 1965
-
Noosa News15 hours agoInquest into Rosemarie Campbell’s death three days after gastric bypass surgery hears of ‘massive loss’ to family
-
Noosa News7 hours agoReubhan Ralph identified as man behind terrifying childcare centre incident in Peregian Springs on the Sunshine Coast
-
General22 hours agoIndonesia airdropped aid for Palestinians in Gaza, but experts question its effectiveness